Guangdong Taienkang Pharmaceutical Co. Ltd (301263) - Total Liabilities

Latest as of June 2025: CN¥690.44 Million CNY ≈ $101.03 Million USD

Based on the latest financial reports, Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has total liabilities worth CN¥690.44 Million CNY (≈ $101.03 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Guangdong Taienkang Pharmaceutical Co. L to assess how effectively this company generates cash.

Guangdong Taienkang Pharmaceutical Co. Ltd - Total Liabilities Trend (2019–2024)

This chart illustrates how Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 301263 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Guangdong Taienkang Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Guangdong Taienkang Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Guangdong Xinbao Electrical Appliances Holdings Co Ltd SHE:002705	China	CN¥6.86 Billion
AECC Aero Science and Technology Co Ltd SHG:600391	China	CN¥5.08 Billion
Payoneer Global Inc NASDAQ:PAYO	USA	$7.45 Billion
SJW Group Common Stock NYSE:SJW	USA	$3.33 Billion
President Securities Corp TW:2855	Taiwan	NT$178.21 Billion
Shenzhen Mason Technologies Co Ltd SHE:002654	China	CN¥3.03 Billion
BHP Group Limited LSE:BHP	UK	GBX60.59 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥2.18 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301263 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangdong Taienkang Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)

The table below shows the annual total liabilities of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥494.67 Million ≈ $72.39 Million	+23.75%
2023-12-31	CN¥399.72 Million ≈ $58.49 Million	+115.33%
2022-12-31	CN¥185.63 Million ≈ $27.16 Million	-19.89%
2021-12-31	CN¥231.71 Million ≈ $33.91 Million	-5.47%
2020-12-31	CN¥245.12 Million ≈ $35.87 Million	+35.31%
2019-12-31	CN¥181.16 Million ≈ $26.51 Million	--

About Guangdong Taienkang Pharmaceutical Co. Ltd

SHE:301263 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.80 Billion

CN¥12.28 Billion CNY

Market Cap Rank

#6678 Global

#1536 in China

Share Price

CN¥28.85

Change (1 day)

+0.70%

52-Week Range

CN¥20.88 - CN¥41.40

All Time High

CN¥41.40